SEC Form 4 · accession 0001127602-16-043524
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 24, 2016
Accepted (ET)
Feb 26, 2016 · 12:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2016 | S | 100 | $72.83 | D | 379,019 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $72.845 | D | 378,919 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $72.85 | D | 378,819 | D | |
| Common Stock | Feb 24, 2016 | S | 200 | $72.89 | D | 378,619 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $72.90 | D | 378,519 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $72.91 | D | 378,419 | D | |
| Common Stock | Feb 24, 2016 | S | 100 | $72.97 | D | 378,319 | D | |
| Common Stock | Feb 24, 2016 | F | 10,463 | $72.53 | D | 367,856 | D | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.